These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1674052)

  • 1. Salmeterol rash.
    Hatton MQ; Allen MB; Mellor EJ; Cooke NJ
    Lancet; 1991 May; 337(8750):1169-70. PubMed ID: 1674052
    [No Abstract]   [Full Text] [Related]  

  • 2. Asthma exacerbations in patients taking regular salmeterol, or salbutamol for symptoms.
    Shepherd GL; Jenkins WJ; Alexander J
    Lancet; 1991 Jun; 337(8754):1424. PubMed ID: 1674807
    [No Abstract]   [Full Text] [Related]  

  • 3. MIASMA: asthma exacerbation reduction with salmeterol.
    Shrewsbury S; Pyke S
    Chest; 2002 Mar; 121(3):1002-4. PubMed ID: 11888994
    [No Abstract]   [Full Text] [Related]  

  • 4. Exacerbations of asthma in patients on salmeterol.
    Jenkins MM; Hilton CJ; de Kock JC; Palmer JB
    Lancet; 1991 Apr; 337(8746):913-4. PubMed ID: 1672988
    [No Abstract]   [Full Text] [Related]  

  • 5. Asthma mortality and beta-agonists.
    Skorodin MS
    Chest; 1995 Dec; 108(6):1768. PubMed ID: 7497807
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory arrests in young asthmatics on salmeterol.
    Shale DJ
    Respir Med; 1994 Jan; 88(1):75-6. PubMed ID: 7913244
    [No Abstract]   [Full Text] [Related]  

  • 7. Salmeterol (Serevent) asthma trial halted early.
    Wooltorton E
    CMAJ; 2003 Mar; 168(6):738. PubMed ID: 12642431
    [No Abstract]   [Full Text] [Related]  

  • 8. Bronchodilator treatment in asthma. Increase in deaths during salmeterol treatment unexplained.
    Sears MR; Taylor DR
    BMJ; 1993 Jun; 306(6892):1610-1. PubMed ID: 8101115
    [No Abstract]   [Full Text] [Related]  

  • 9. Long acting beta 2 agonists and the risk of life threatening asthma.
    Ernst P
    Thorax; 1998 Jan; 53(1):1-2. PubMed ID: 9577513
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta2 déjà vu.
    O'Byrne PM; Adelroth E
    Chest; 2006 Jan; 129(1):3-5. PubMed ID: 16424402
    [No Abstract]   [Full Text] [Related]  

  • 11. Safety of long-acting beta-agonists--an urgent need to clear the air.
    Martinez FD
    N Engl J Med; 2005 Dec; 353(25):2637-9. PubMed ID: 16371628
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on the Salmeterol Multicenter Asthma Research Trial.
    Seymour SM; Sullivan EJ; Chowdhury BA; Meyer RJ; Davi RC
    Chest; 2006 Sep; 130(3):930-1; author reply 931. PubMed ID: 16963702
    [No Abstract]   [Full Text] [Related]  

  • 13. Can beta agonists cause dilated cardiomyopathy?
    Choudhary AS; Robinson GM
    Heart Lung Circ; 2009 Oct; 18(5):367-9. PubMed ID: 19081299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of beta(2)-agonists in children.
    Kabesch M
    J Allergy Clin Immunol; 2009 Dec; 124(6):1195-6. PubMed ID: 19910024
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-acting beta-agonists, tachyphylaxis, and corticosteroids.
    Sears MR
    Chest; 1996 Apr; 109(4):862-4. PubMed ID: 8635359
    [No Abstract]   [Full Text] [Related]  

  • 16. Why SMART about second-line treatment when first-line treatment is being ignored?
    Currie GP
    Chest; 2006 Sep; 130(3):929; author reply 929. PubMed ID: 16963701
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA alerts asthmatics to drug safety risk.
    Ellis C
    Nat Rev Drug Discov; 2003 Oct; 2(10):765. PubMed ID: 14577428
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta2 agonists and heart failure.
    Lindmark B; Ottosson A
    Lancet; 1998 Nov; 352(9141):1709-10. PubMed ID: 9853469
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of salmeterol xinafoate in the treatment of COPD.
    Mahler DA; Donohue JF; Barbee RA; Goldman MD; Gross NJ; Wisniewski ME; Yancey SW; Zakes BA; Rickard KA; Anderson WH
    Chest; 1999 Apr; 115(4):957-65. PubMed ID: 10208192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.